Irving Institute Announces 2018 Irving Scholars

The Irving Institute for Clinical and Translational Research, home to Columbia University’s Clinical and Translational Science Award (CTSA) Program hub, announces the 2018 Irving Scholars.

Irving Scholars are selected on the basis of research proposals that reflect independent, well-developed scientific initiative in clinical investigation. The ranks of the scholars appointed since the program was launched in 1987 include physicians who have since become internationally recognized for their work.

The 2018-2021 Irving Scholars are:

Swarnali Acharyya, Pathology and Cell Biology
Diagnosing & Targeting Cachexia to prolong patient survival

Guillermo Horga, Psychiatry
Investigating the use of neuromelanin-sensitive MRI for risk staging of psychosis

Kevin Kalinsky, Medicine: Hematology and Oncology
Clinical Trial of Systems-biology Directed Therapy in Patients with Metastatic Triple Negative Breast Cancer

Max O'Donnell, Medicine: Pulmonary, Allergy, and Critical Care
A precision medicine approach to enhanced detection and genomic characterization of emerging respiratory pathogens in Uganda

Elizabeth Oelsner, Medicine: General Medicine
E-Cigarette effects on sputum biology: identifying extent and susceptibility in healthy adults

Yvonne Saenger, Medicine: Hematology and Oncology
Establishing a prognostic immune signature in early stage melanoma by measuring mRNA transcripts using the NanoString assay and quantitative multiplexed immuno-fluorescence